Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAVXG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,627
Award facts
- Contract value 100% obligated
- $36,626.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,626.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Dupixent 300 mg/2 ml pen injections. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The Dupixent delivery fulfills the company's ongoing role in supporting the military's pharmaceutical supply needs through the established indefinite delivery contract framework.
Quick answers
Who was awarded contract SPE2DB25FAVXG?
SPE2DB25FAVXG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FAVXG worth?
The government has obligated $36,627 on SPE2DB25FAVXG.
Is contract SPE2DB25FAVXG an order under another contract?
Yes. SPE2DB25FAVXG is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVXG competed?
The extent of competition for SPE2DB25FAVXG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award